Viewing Study NCT00251082



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00251082
Status: COMPLETED
Last Update Posted: 2008-03-12
First Post: 2005-11-08

Brief Title: Vasomotoric Symptoms Study of a 05 mg Estradiol and 25 mg Dydrogesterone Combination
Sponsor: Solvay Pharmaceuticals
Organization: Solvay Pharmaceuticals

Study Overview

Official Title: A Randomized Placebo-Controlled Double-Blind Multi-National Study to Demonstrate Efficacy of Continuous Combined 05 mg Estradiol and 25 mg Dydrogesterone in the Treatment of Vasomotor Symptoms in Postmenopausal Women in Comparison to Placebo Over 3 Months and to Investigate the Bleeding Pattern Over a Double-Blind Treatment Period of One Year Compared With Continuous Combined 1 mg Estradiol and 5 mg Dydrogesterone
Status: COMPLETED
Status Verified Date: 2008-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To demonstrate efficacy of continuous combined 05 mg estradiol and 25 mg dydrogesterone versus placebo in the treatment of vasomotor symptoms after a treatment period of 3 months and to investigate the bleeding pattern over a treatment period of one year
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2004-00215-25 None None None